Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-03-18 4:08 pm | N/A N/A | ProQR Therapeutics N.V. | PRQR | Valerio Domenico Director | 0 | $0 | 971,291 (Direct) | View |
Ownership | 2026-03-18 4:08 pm | N/A N/A | ProQR Therapeutics N.V. | PRQR | Platenburg Gerardus Johannes Chief Scientific Officer | 0 | $0 | 2,107,698 (Direct) | View |
Ownership | 2026-03-18 4:07 pm | N/A 2032-02-29 | ProQR Therapeutics N.V. | PRQR | Maier Martin Alexander Director | 0 | $0 | 63,006 (Direct) | View |
Ownership | 2026-03-18 4:05 pm | N/A 2026-06-20 | ProQR Therapeutics N.V. | PRQR | Lawton Alison Frances Director | 0 | $0 | 245,599 (Direct) | View |
Ownership | 2026-03-18 4:04 pm | N/A 2035-04-30 | ProQR Therapeutics N.V. | PRQR | Hom Dennis Chief Financial Officer | 0 | $0 | 1,000,000 (Direct) | View |
Ownership | 2026-03-18 4:04 pm | N/A N/A | ProQR Therapeutics N.V. | PRQR | HEGGIE THERESA Director | 0 | $0 | 449,188 (Direct) | View |
Ownership | 2026-03-18 4:03 pm | N/A 2029-05-20 | ProQR Therapeutics N.V. | PRQR | Filius Bart Director | 0 | $0 | 177,957 (Direct) | View |
Ownership | 2026-03-18 4:02 pm | N/A 2026-12-31 | ProQR Therapeutics N.V. | PRQR | de Boer Daniel Anton Chief Executive Officer | 0 | $0 | 6,740,669 (Direct) | View |
Ownership | 2026-03-18 4:01 pm | N/A 2032-10-31 | ProQR Therapeutics N.V. | PRQR | Carreno-Gomez Begona Director | 0 | $0 | 97,277 (Direct) | View |
Ownership | 2026-03-18 4:01 pm | N/A N/A | ProQR Therapeutics N.V. | PRQR | Shannon James Samuel Director | 0 | $0 | 334,391 (Direct) | View |